Skip to main content
Fig. 2 | Breast Cancer Research

Fig. 2

From: Effect of neoadjuvant chemotherapy on tumor-infiltrating lymphocytes and PD-L1 expression in breast cancer and its clinical significance

Fig. 2

Survival analysis of patients with residual disease following post-neoadjuvant treatment based on ΔTILs and PD-L1 expression. a Five-year recurrence-free survival (RFS) Kaplan–Meier curve of stromal TIL change (increase or decrease) following neoadjuvant treatment. b Five-year overall survival (OS) Kaplan–Meier curve of stromal TIL change (increase or decrease) following neoadjuvant treatment. c Five-year RFS Kaplan–Meier curve of PD-L1 status (positive or negative) in post-neoadjuvant cases. Positivity based on the visual cutoff of 500 AQUA method units. d Five-year OS Kaplan–Meier curve of PD-L1 status (positive or negative) in post-neoadjuvant cases. TIL tumor infiltrating lymphocyte, PD-L1 programmed death ligand 1

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us